Myriad Genetics (MYGN) Change in Account Payables (2009 - 2026)
Myriad Genetics (MYGN) posted quarterly Change in Account Payables of $5.4 million for Q1 2026, up 228.57% quarter-over-quarter from -$4.2 million in Q4 2025.
Myriad Genetics (MYGN) Change in Account Payables (2009 - 2026) Analysis & Trends
Myriad Genetics (MYGN) has reported Change in Account Payables for 18 consecutive years, with $5.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables changed N/A year-over-year to $5.4 million; the TTM figure through Mar 2026 stood at $4.0 million (up 385.71% YoY), while the FY2025 annual figure was -$1.4 million, down 129.79% from the prior year.
- Change in Account Payables rose to $5.4 million in Q1 2026 per MYGN's latest filing, from -$4.2 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $7.6 million in Q1 2023 and bottomed at -$8.5 million in Q3 2023.
- Historically, Change in Account Payables has averaged $93750.0 across 5 years, with a median of -$950000.0 in 2024.
- Annual changes were most pronounced in 2022 — Change in Account Payables tumbled 1166.67% — and 2023, when it soared 337.5%.
- Myriad Genetics' Change in Account Payables stood at -$2.4 million in 2022, then tumbled by 145.83% to -$5.9 million in 2023, then soared by 81.36% to -$1.1 million in 2024, then sank by 281.82% to -$4.2 million in 2025, then surged by 228.57% to $5.4 million in 2026.
- Business Quant data shows MYGN's Change in Account Payables at $5.4 million in Q1 2026, -$4.2 million in Q4 2025, and -$800000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | - |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -38.00 Mn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -6.74 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 15.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | - |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 21.88 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 10.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 674,000.00 |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | - |
| 10 | Myriad Genetics | 297.97 Mn | 173.57 Mn | 137.60 Mn | 5.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.40 Mn |
| Mar 31, 2026 | 5.40 Mn |
| Dec 31, 2025 | -4.20 Mn |
| Dec 31, 2025 | -4.20 Mn |
| Sep 30, 2025 | -800,000.00 |
| Sep 30, 2025 | -800,000.00 |
| Jun 30, 2025 | 3.60 Mn |
| Jun 30, 2025 | 3.60 Mn |
| Dec 31, 2024 | -1.10 Mn |
| Dec 31, 2024 | -1.10 Mn |
| Sep 30, 2024 | -3.60 Mn |
| Sep 30, 2024 | -3.60 Mn |
| Jun 30, 2024 | 3.30 Mn |
| Jun 30, 2024 | 3.30 Mn |
| Mar 31, 2024 | 6.10 Mn |
| Mar 31, 2024 | 6.10 Mn |
| Dec 31, 2023 | -5.90 Mn |
| Dec 31, 2023 | -5.90 Mn |
| Sep 30, 2023 | -8.50 Mn |
| Sep 30, 2023 | -8.50 Mn |